CD22 and diffuse large B-cell lymphoma: A dog with spontaneous DLBCL was subjected to a SPECT-CT imaging with an indium-111-radiolabeled anti-CD22 antibody as part of disease staging in order to obtain the proof of concept of the relevance of this antibody in a veterinary clinical trial.